BillionToOne, Inc. (BLLN) vs Cogent Biosciences, Inc. (COGT)
A side-by-side comparison of BillionToOne, Inc. and Cogent Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLLN
BillionToOne, Inc.
$109.06HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
COGT
Cogent Biosciences, Inc.
$30.87HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BLLN vs COGT
growth of $100 · dividends reinvested · last 1yBLLN +0.1% (+0.1%/yr)COGT +118.5% (+118.5%/yr)COGT compounded faster over this window
BLLN COGT
BLLN vs COGT: by the numbers
- •COGT is the larger company ($5.27B vs $5.02B market cap).
- •BLLN is profitable (8.43% net margin) while COGT runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BLLN | COGT |
|---|---|---|
| P/E ratio | 175.87 | N/A |
| Forward P/E | 137.31 | N/A |
| P/S ratio | 12.62 | N/A |
| P/B ratio | 9.34 | 11.28 |
| EV / EBITDA | 82.94 | N/A |
| FCF yield | 0.66% | N/A |
Profitability
| Metric | BLLN | COGT |
|---|---|---|
| Gross margin | 71.27% | 0.00% |
| Operating margin | 10.90% | 0.00% |
| Net margin | 8.43% | 0.00% |
| ROE | 6.24% | -70.85% |
| ROIC | 6.39% | -50.09% |
Growth (annualized)
| Metric | BLLN | COGT |
|---|---|---|
| Total return CAGR (5Y) | N/A | 28.51% |
Frequently asked
- Is BLLN or COGT more profitable?
- BLLN runs the higher net margin — BLLN at 8.43% versus COGT at 0.00%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.